Approach to the Patient with MODY-Monogenic Diabetes
Open accessThe DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Abstract
Maturity-onset diabetes of the young, or MODY-monogenic diabetes, is a not-so-rare collection of inherited disorders of non-autoimmune diabetes mellitus that remains insufficiently diagnosed despite increasing awareness. These cases are important to efficiently and accurately diagnose, given the clinical implications of syndromic features, cost-effective treatment regimen, and the potential impact on multiple family members. Proper recognition of the clinical manifestations, family history, and cost-effective lab and genetic testing provide the diagnosis. All patients must undergo a thorough history, physical examination, multigenerational family history, lab evaluation (glycated hemoglobin A1c [HbA1c], glutamic acid decarboxylase antibodies [GADA], islet antigen 2 antibodies [IA-2A], and zinc transporter 8 [ZnT8] antibodies). The presence of clinical features with 3 (or more) negative antibodies may be indicative of MODY-monogenic diabetes, and is followed by genetic testing. Molecular genetic testing should be performed before attempting specific treatments in most cases. Additional testing that is helpful in determining the risk of MODY-monogenic diabetes is the MODY clinical risk calculator (>25% post-test probability in patients not treated with insulin within 6 months of diagnosis should trigger genetic testing) and 2-hour postprandial (after largest meal of day) urinary C-peptide to creatinine ratio (with a ≥0.2 nmol/mmol to distinguish HNF1A- or 4A-MODY from type 1 diabetes). Treatment, as well as monitoring for microvascular and macrovascular complications, is determined by the specific variant that is identified. In addition to the diagnostic approach, this article will highlight recent therapeutic advancements when patients no longer respond to first-line therapy (historically sulfonylurea treatment in many variants). Learning Objectives: Upon completion of this educational activity, participants should be able to: Target Audience: This continuing medical education activity should be of substantial interest to endocrinologists and all health care professionals who care for people with diabetes mellitus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A glucose level ≥200 mg/dL in the presence of hyperglycemia symptoms such as polyuria and polydipsia confirm the diagnosis of DM.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
Baekkeskov, S., Aanstoot, H.-J., Christgai, S., Reetz, A., Solimena, M., Cascalho, M., Folli, F., Richter-Olesen, H., & Camilli, P.-D. (1990) · Nature · doi:10.1038/347151a0 · Cited by 1,964
Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
Fajans, S. S., Bell, G. I., & Polonsky, K. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmra002168 · Cited by 1,123
Thorens, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8641 · Cited by 906
Maturity-onset diabetes of the young (MODY): how many cases are we missing?
Shields, B. M., Hicks, S., Shepherd, M. H., Colclough, K., Hattersley, A. T., & Ellard, S. (2010) · Diabetologia · doi:10.1007/s00125-010-1799-4 · Cited by 725
The clinical utility of C‐peptide measurement in the care of patients with diabetes
Jones, A. G., & Hattersley, A. T. (2013) · Diabetic Medicine · doi:10.1111/dme.12159 · Cited by 628
Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus
Malecki, M. T., Jhala, U. S., Antonellis, A., Fields, L., Doria, A., Orban, T., Saad, M., Warram, J. H., Montminy, M., & Krolewski, A. S. (1999) · Nature Genetics · doi:10.1038/15500 · Cited by 619
Genetic cause of hyperglycaemia and response to treatment in diabetes
Pearson, E. R., Starkey, B. J., Powell, R. J., Gribble, F. M., Clark, P. M., & Hattersley, A. T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14571-0 · Cited by 607
Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young
Ellard, S., Bellanné-Chantelot, C., Hattersley, A. T., & European Molecular Genetics Quality Network (EMQN) MODY group (2008) · Diabetologia · doi:10.1007/s00125-008-0942-y · Cited by 433
Pihoker, C., Gilliam, L. K., Ellard, S., Dabelea, D., Davis, C., Dolan, L. M., Greenbaum, C. J., Imperatore, G., Lawrence, J. M., Marcovina, S. M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1279 · Cited by 397
Insulin Mutation Screening in 1,044 Patients With Diabetes
Edghill, E. L., Flanagan, S. E., Patch, A.-M., Boustred, C., Parrish, A., Shields, B., Shepherd, M. H., Hussain, K., Kapoor, R. R., Malecki, M., et al. (2008) · Diabetes · doi:10.2337/db07-1405 · Cited by 397
Self-citationSteele, A. M., Shields, B. M., Wensley, K. J., Colclough, K., Ellard, S., & Hattersley, A. T. (2014) · JAMA · doi:10.1001/jama.2013.283980 · Cited by 381
Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction
Ræder, H., Johansson, S., Holm, P. I., Haldorsen, I. S., Mas, E., Sbarra, V., Nermoen, I., Eide, S. Å., Grevle, L., Bjørkhaug, L., et al. (2006) · Nature Genetics · doi:10.1038/ng1708 · Cited by 376
Clinical Spectrum Associated with Hepatocyte Nuclear Factor-1β Mutations
Bellanné-Chantelot, C., Chauveau, D., Gautier, J.-F., Dubois-Laforgue, D., Clauin, S., Beaufils, S., Wilhelm, J.-M., Boitard, C., Noël, L.-H., Velho, G., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-7-200404060-00009 · Cited by 358
De Franco, E., Flanagan, S. E., Houghton, J. A., Allen, H. L., Mackay, D. J., Temple, I. K., Ellard, S., & Hattersley, A. T. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60098-8 · Cited by 349
Shields, B. M., McDonald, T. J., Ellard, S., Campbell, M. J., Hyde, C., & Hattersley, A. T. (2012) · Diabetologia · doi:10.1007/s00125-011-2418-8 · Cited by 335
Fajans, S. S., & Bell, G. I. (2011) · Diabetes Care · doi:10.2337/dc11-0035 · Cited by 320
Wolfram Syndrome: Diagnosis, Management, and Treatment
Urano, F. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0702-6 · Cited by 307
Precision diabetes: learning from monogenic diabetes
Hattersley, A. T., & Patel, K. A. (2017) · Diabetologia · doi:10.1007/s00125-017-4226-2 · Cited by 306
Chakera, A. J., Steele, A. M., Gloyn, A. L., Shepherd, M. H., Shields, B., Ellard, S., & Hattersley, A. T. (2015) · Diabetes Care · doi:10.2337/dc14-2769 · Cited by 289
(2004) · Controlled Clinical Trials · doi:10.1016/j.cct.2004.08.002 · Cited by 268
Renal Phenotypes Related to Hepatocyte Nuclear Factor-1β (TCF2) Mutations in a Pediatric Cohort
Ulinski, T., Lescure, S., Beaufils, S., Guigonis, V., Decramer, S., Morin, D., Clauin, S., Desche[Combining Circumflex Accent]nes, G., Bouissou, F. C., Bensman, A., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005101040 · Cited by 265
The diagnosis and management of monogenic diabetes in children and adolescents
Hattersley, A., Bruining, J., Shield, J., Njolstad, P., & Donaghue, K. C. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00571.x · Cited by 255
Autoantibodies in type 1 diabetes
Taplin, C. E., & Barker, J. M. (2008) · Autoimmunity · doi:10.1080/08916930701619169 · Cited by 250
Shepherd, M., Shields, B., Ellard, S., Rubio‐Cabezas, O., & Hattersley, A. T. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02690.x · Cited by 241
Achenbach, P., Koczwara, K., Knopff, A., Naserke, H., Ziegler, A.-G., & Bonifacio, E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421307 · Cited by 239
Shepherd, M., Shields, B., Hammersley, S., Hudson, M., McDonald, T. J., Colclough, K., Oram, R. A., Knight, B., Hyde, C., Cox, J., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0645 · Cited by 236
Pearson, E. R., Pruhova, S., Tack, C. J., Johansen, A., Castleden, H. A. J., Lumb, P. J., Wierzbicki, A. S., Clark, P. M., Lebl, J., Pedersen, O., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1738-y · Cited by 232
Diagnosis, management, and prognosis of HNF1B nephropathy in adulthood
Faguer, S., Decramer, S., Chassaing, N., Bellanné-Chantelot, C., Calvas, P., Beaufils, S., Bessenay, L., Lengelé, J.-P., Dahan, K., Ronco, P., et al. (2011) · Kidney International · doi:10.1038/ki.2011.225 · Cited by 224
Colclough, K., Bellanne-Chantelot, C., Saint-Martin, C., Flanagan, S. E., & Ellard, S. (2013) · Human Mutation · doi:10.1002/humu.22279 · Cited by 224
Meier, J. J., & Nauck, M. A. (2010) · Diabetes · doi:10.2337/db09-1899 · Cited by 215
Stride, A., Shields, B., Gill-Carey, O., Chakera, A. J., Colclough, K., Ellard, S., & Hattersley, A. T. (2014) · Diabetologia · doi:10.1007/s00125-013-3075-x · Cited by 212
Whole-Exome Sequencing and High Throughput Genotyping Identified KCNJ11 as the Thirteenth MODY Gene
Bonnefond, A., Philippe, J., Durand, E., Dechaume, A., Huyvaert, M., Montagne, L., Marre, M., Balkau, B., Fajardy, I., Vambergue, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037423 · Cited by 204
Type 1 Diabetes Genetic Risk Score: A Novel Tool to Discriminate Monogenic and Type 1 Diabetes
Patel, K. A., Oram, R. A., Flanagan, S. E., De Franco, E., Colclough, K., Shepherd, M., Ellard, S., Weedon, M. N., & Hattersley, A. T. (2016) · Diabetes · doi:10.2337/db15-1690 · Cited by 195
Mutations at the BLK locus linked to maturity onset diabetes of the young and β-cell dysfunction
Borowiec, M., Liew, C. W., Thompson, R., Boonyasrisawat, W., Hu, J., Mlynarski, W. M., El Khattabi, I., Kim, S.-H., Marselli, L., Rich, S. S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906474106 · Cited by 189
Heterozygous ABCC8 mutations are a cause of MODY
Bowman, P., Flanagan, S. E., Edghill, E. L., Damhuis, A., Shepherd, M. H., Paisey, R., Hattersley, A. T., & Ellard, S. (2012) · Diabetologia · doi:10.1007/s00125-011-2319-x · Cited by 177
Treatment options for MODY patients: a systematic review of literature
Delvecchio, M., Pastore, C., & Giordano, P. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00864-4 · Cited by 172
Meur, G., Simon, A., Harun, N., Virally, M., Dechaume, A., Bonnefond, A., Fetita, S., Tarasov, A. I., Guillausseau, P.-J., Boesgaard, T. W., et al. (2010) · Diabetes · doi:10.2337/db09-1091 · Cited by 152
Loss-of-Function Mutations in APPL1 in Familial Diabetes Mellitus
Prudente, S., Jungtrakoon, P., Marucci, A., Ludovico, O., Buranasupkajorn, P., Mazza, T., Hastings, T., Milano, T., Morini, E., Mercuri, L., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.05.011 · Cited by 148
Østoft, S. H., Bagger, J. I., Hansen, T., Pedersen, O., Faber, J., Holst, J. J., Knop, F. K., & Vilsbøll, T. (2014) · Diabetes Care · doi:10.2337/dc13-3007 · Cited by 136
Naylor, R. N., John, P. M., Winn, A. N., Carmody, D., Greeley, S. A. W., Philipson, L. H., Bell, G. I., & Huang, E. S. (2014) · Diabetes Care · doi:10.2337/dc13-0410 · Cited by 134
Self-citationSteele, A. M., Wensley, K. J., Ellard, S., Murphy, R., Shepherd, M., Colclough, K., Hattersley, A. T., & Shields, B. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065326 · Cited by 133
Besser, R. E. J., Shepherd, M. H., McDonald, T. J., Shields, B. M., Knight, B. A., Ellard, S., & Hattersley, A. T. (2011) · Diabetes Care · doi:10.2337/dc10-1293 · Cited by 133
Steele, A. M., Shields, B. M., Shepherd, M., Ellard, S., Hattersley, A. T., & Pearson, E. R. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02913.x · Cited by 130
Shepherd, M., Pearson, E. R., Houghton, J., Salt, G., Ellard, S., & Hattersley, A. T. (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3191-a · Cited by 129
Thanabalasingham, G., Shah, N., Vaxillaire, M., Hansen, T. F., Tuomilehto, J., Gašperíková, D., Szopa, M., Tjora, E., James, T. J., Kokko, P., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2261-y · Cited by 128
Menzel, R., Kaisaki, P. J., Rjasanowski, I., Heinke, P., Kerner, W., & Menzel, S. (1998) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199810)15:10<816::aid-dia714>3.0.co;2-p · Cited by 127
Influence of maternal and fetal glucokinase mutations in gestational diabetes
Spyer, G., Hattersley, A. T., Sykes, J. E., Sturley, R., & MacLeod, K. M. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.113127 · Cited by 116
Neonatal Diabetes: An Expanding List of Genes Allows for Improved Diagnosis and Treatment
Greeley, S. A. W., Naylor, R. N., Philipson, L. H., & Bell, G. I. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0234-7 · Cited by 115
Self-citationCarlsson, A., Shepherd, M., Ellard, S., Weedon, M., Lernmark, Å., Forsander, G., Colclough, K., Brahimi, Q., Valtonen-Andre, C., Ivarsson, S. A., et al. (2020) · Diabetes Care · doi:10.2337/dc19-0747 · Cited by 111
MODY in Iceland is associated with mutations in HNF -1? and a novel mutation in NeuroD1
Kristinsson, S. Y., Talseth‐Palmer, B. A., Steingrı́msson, E., Þórsson, Á. V., Helgason, T., Hreidarsson, Á. B., Thorolfsdottir, E. T., & Arngrı́msson, R. (2001) · Diabetologia · doi:10.1007/s001250100016 · Cited by 110
Gromada, J., Ding, W.-G., Barg, S., Renström, E., & Rorsman, P. (1997) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s004240050431 · Cited by 110
High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes
McDonald, T. J., Shields, B. M., Lawry, J., Owen, K. R., Gloyn, A. L., Ellard, S., & Hattersley, A. T. (2011) · Diabetes Care · doi:10.2337/dc11-0323 · Cited by 105
Kleinberger, J. W., Copeland, K. C., Gandica, R. G., Haymond, M. W., Levitsky, L. L., Linder, B., Shuldiner, A. R., Tollefsen, S., White, N. H., & Pollin, T. I. (2018) · Genetics in Medicine · doi:10.1038/gim.2017.150 · Cited by 104
Tuomi, T., Honkanen, E. H., Isomaa, B., Sarelin, L., & Groop, L. C. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1314 · Cited by 100
Distinguishing Persistent Insulin Autoantibodies With Differential Risk
Yu, L., Miao, D., Scrimgeour, L. A., Johnson, K. C., Rewers, M., & Eisenbarth, G. S. (2011) · Diabetes · doi:10.2337/db11-0670 · Cited by 96
Clinical spectrum associated with hepatocyte nuclear factor-1bêta mutations.
Bellanne-Chantelot, Chauveau, Gautier, & Dubois-Laforgue (2004) · Annals of Internal Medicine · Cited by 95
Fajans, S. S., & Brown, M. B. (1993) · Diabetes Care · doi:10.2337/diacare.16.9.1254 · Cited by 94
Bacon, S., Kyithar, M. P., Rizvi, S. R., Donnelly, E., McCarthy, A., Burke, M., Colclough, K., Ellard, S., & Byrne, M. M. (2016) · Diabetic Medicine · doi:10.1111/dme.12992 · Cited by 94
Genetics of Monogenic Diabetes: Present Clinical Challenges
Misra, S., & Owen, K. R. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1111-4 · Cited by 83
Urbanová, J., Rypáčková, B., Procházková, Z., Kučera, P., Černá, M., Anděl, M., & Heneberg, P. (2014) · Diabetic Medicine · doi:10.1111/dme.12314 · Cited by 80
Maturity onset diabetes of the young and pregnancy
Colom, C., & Corcoy, R. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.05.008 · Cited by 79
Wenzlau, J. M., Walter, M., Gardner, T. J., Frisch, L. M., Yu, L., Eisenbarth, G. S., Ziegler, A.-G., Davidson, H. W., & Hutton, J. C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0169 · Cited by 74
Gutniak, M. K., Juntti-Berggren, L., Hellström, P. M., Guenifi, A., Holst, J. J., & Efendic, S. (1996) · Diabetes Care · doi:10.2337/diacare.19.8.857 · Cited by 70
Hope, S. V., Knight, B. A., Shields, B. M., Hattersley, A. T., McDonald, T. J., & Jones, A. G. (2016) · Diabetic Medicine · doi:10.1111/dme.13142 · Cited by 68
Bacon, S., Schmid, J., McCarthy, A., Edwards, J., Fleming, A., Kinsley, B., Firth, R. G., Byrne, B., Gavin, C., & Byrne, M. M. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.04.037 · Cited by 58
Montoli, A., Colussi, G., Massa, O., Caccia, R., Rizzoni, G., Civati, G., & Barbetti, F. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.34538 · Cited by 57
Ovsyannikova, A. K., Rymar, O. D., Shakhtshneider, E. V., Klimontov, V. V., Koroleva, E. A., Myakina, N. E., & Voevoda, M. I. (2016) · Diabetes Therapy · doi:10.1007/s13300-016-0192-9 · Cited by 56
Maturity-Onset Diabetes of the Young Overview
Naylor, R. N., Johnson, A. K., & del Gaudio, D. (2018) · Cited by 56
Aaboe, K., Knop, F. K., Vilsboll, T., Vølund, A., Simonsen, U., Deacon, C. F., Madsbad, S., Holst, J. J., & Krarup, T. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1731 · Cited by 53
Meglitinide Analogues in Adolescent Patients With HNF1A-MODY (MODY 3)
Becker, M., Galler, A., & Raile, K. (2014) · Pediatrics · doi:10.1542/peds.2012-2537 · Cited by 51
Clinical and Metabolic Features of Adult-Onset Diabetes Caused by ABCC8 Mutations
Riveline, J.-P., Rousseau, E., Reznik, Y., Fetita, S., Philippe, J., Dechaume, A., Hartemann, A., Polak, M., Petit, C., Charpentier, G., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1469 · Cited by 50
Misra, S., Shields, B. M., Colclough, K., Johnston, D. G., Oliver, N. S., Ellard, S., & Hattersley, A. T. (2016) · Diabetologia · doi:10.1007/s00125-016-4056-7 · Cited by 50
Christensen, A. S., Hædersdal, S., Støy, J., Storgaard, H., Kampmann, U., Forman, J. L., Seghieri, M., Holst, J. J., Hansen, T., Knop, F. K., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0408 · Cited by 48
Liu, L., Nagashima, K., Yasuda, T., Liu, Y., Hu, H., He, G., Feng, B., Zhao, M., Zhuang, L., Zheng, T., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-3031-9 · Cited by 47
Age at Onset of Type 1 Diabetes in Parents and Recurrence Risk in Offspring
Harjutsalo, V., Lammi, N., Karvonen, M., & Groop, P.-H. (2010) · Diabetes · doi:10.2337/db09-0344 · Cited by 46
Hohendorff, J., Szopa, M., SKUPIEN, J. K., Kapusta, M., Zapała, B., Płatek, T., Mrozińska, S., Parpan, T., Głodzik, W., Ludwig-Galezowska, A. H., et al. (2017) · Endocrine · doi:10.1007/s12020-017-1341-2 · Cited by 45
Hope, S. V., Knight, B. A., Shields, B. M., Hill, A. V., Choudhary, P., Strain, W. D., McDonald, T. J., & Jones, A. G. (2018) · Diabetologia · doi:10.1007/s00125-017-4449-2 · Cited by 41
Novel Use of GLP-1 Receptor Agonist Therapy in HNF4A-MODY
Broome, D. T., Tekin, Z., Pantalone, K. M., & Mehta, A. (2020) · Diabetes Care · doi:10.2337/dc20-0012 · Cited by 39
Self-citationTwo Cases of Diabetic Ketoacidosis in HNF1A-MODY Linked to Severe Dehydration
Průhová, Š., Dušátková, P., Neumann, D., Hollay, E., Cinek, O., Lebl, J., & Šumník, Z. (2013) · Diabetes Care · doi:10.2337/dc13-0058 · Cited by 38
Awa, W. L., Schober, E., Wiegand, S., Herwig, J., Meissner, T., Schmidt, F., Molz, E., & Holl, R. W. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.09.011 · Cited by 35
Diagnosis of monogenic diabetes: 10‐Year experience in a large multi‐ethnic diabetes center
Thomas, E. R. A., Brackenridge, A., Kidd, J., Kariyawasam, D., Carroll, P., Colclough, K., & Ellard, S. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12432 · Cited by 33
Docena, M. K., Faiman, C., Stanley, C. M., & Pantalone, K. M. (2013) · Endocrine Practice · doi:10.4158/ep13254.or · Cited by 31
Self-citationTreatment of HNF1‐alpha MODY with the DPP‐4 inhibitor Sitagliptin1
Lumb, A. N., & GALLEN, I. W. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02645.x · Cited by 28
Christensen, A. S., Hædersdal, S., Storgaard, H., Rose, K., Hansen, N. L., Holst, J. J., Hansen, T. F., Knop, F. K., & Vilsbøll, T. (2020) · Diabetes · doi:10.2337/db20-0074 · Cited by 27
Bacon, S., Kyithar, M. P., Condron, E. M., Vizzard, N., Burke, M., & Byrne, M. M. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0890-9 · Cited by 23
Fantasia, K. L., & Steenkamp, D. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00278 · Cited by 23
Diabetes Case Studies: Real Problems, Practical Solutions
Suzi Kochar, M., Janice L. Gilden, M., Azmi, S., Malik, R. A., Vince N. Montes, M., Chait, A., Craig E. Taplin, M., Robert H. Slover, M., Ipp, E., Kristina Djekic, M., et al. (2015) · American Diabetes Association eBooks · doi:10.2337/9781580405713 · Cited by 8
Abstract #224: Euglycemic DKA in Mody Patient: Empagliflozin to Blame
Magdaleno, A. L., Venkataraman, S., & Perilli, G. (2017) · Endocrine Practice · doi:10.1016/s1530-891x(20)44344-7 · Cited by 3
Maturity-Onset Diabetes of the Young Overview -- GeneReviews®
Adam, M. P., Hh, A., Ra, P., Se, W., Ljh, B., Stephens, K. D., & Amemiya, A. (2019) · Cited by 2
Euglycemic DKA in MODY Patient: Empagliflozin to Blame.
Magdaleno, A. L., Venkataraman, S., & Perilli, G. (2017) · Cited by 1
Research works printed but not linked: 1
- 66. VCV000447521.1—ClinVar—NCBI. https://www.ncbi.nlm.nih.gov/clinvar/variation/447521/. Accessed May 24, 2020.
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Precision diabetes: Lessons learned from maturity‐onset diabetes of the young (MODY)
Tosur, M., & Philipson, L. H. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13860 · Cited by 110
Self-citationThe β Cell in Diabetes: Integrating Biomarkers With Functional Measures
Kahn, S. E., Chen, Y., Esser, N., Taylor, A. J., van Raalte, D. H., Zraika, S., & Verchere, C. B. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab021 · Cited by 80
“Importantly, the identification of the MODY subtype results in different therapeutic strategies (3, 11, 12, 241).”
BackgroundMaturity Onset Diabetes of the Young—New Approaches for Disease Modelling
Skoczek, D., Dulak, J., & Kachamakova‐Trojanowska, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147553 · Cited by 48
Definition, Classification, Diagnosis and Differential Diagnosis of Diabetes Mellitus: Update 2023
Pleus, S., Tytko, A., Landgraf, R., Heinemann, L., Werner, C., Müller‐Wieland, D., Ziegler, A., Müller, U. A., Freckmann, G., Kleinwechter, H. J., et al. (2024) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2166-6643 · Cited by 45
Metadata
- Authors
- Broome, D. T., Pantalone, K. M., Kashyap, S. R., & Philipson, L. H.
- Affiliations
- Cleveland Clinic (US)
- University of Chicago (US)
- Corresponding author
- Broome, David T
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2020-10-09
- Volume
- 106
- Issue
- 1
- Pages
- 237-250
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC7765647
- OpenAlex
- W3092354470
- Cited by
- 159
- References
- 93
- Citations by year
- 2026: 24 · 2025: 33 · 2024: 29 · 2023: 40 · 2022: 22 · 2021: 11
- FWCI
- 10.70
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (DK118612-01, R01DK104942, P30DK020595)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- maturity-onset diabetes of the young, monogenic diabetes, HNF1A-MODY, genetic testing, islet autoantibodies, urinary C-peptide, sulfonylurea therapy, microvascular complications, family history (medicine)
- MeSH terms
- Diabetes Mellitus, Type 2, Genetic Testing, Humans, Hypoglycemic Agents, Male, Patient-Centered Care, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.